Morning Watchlist

    These Execs Are Buying the Dip — Should You? - 6/9

    Ian Cooper
    Monday, June 9, 20254 min read
    These Execs Are Buying the Dip — Should You? - 6/9

    many corporate executives take it as a buying opportunity — especially if they believe their companies are poised for a turnaround.

    Right now, we're seeing three notable insider purchases that investors should keep a close eye on:

    Company: $1.24 Million Insider Buy

    Discount retailer 36%, significantly outperforming the broader outperformed in soft or recessionary macro environments.

    CFRA Research recently noted, Stewart Glendinning made a bold move: He purchased $1.24 million, at an average price of “dark horse winner” in the new tariff environment. With U.S.-China trade tensions escalating, companies that can adapt their pricing models may find hidden upside.

    According to Citi:

    “While Dollar Tree was previously trying to manage China tariffs within its current pricing architecture, this higher tariff regime gives them further cover to expand price points from $1.25 to $1.50 - $1.75.”

    That kind of pricing flexibility — combined with defensive sector tailwinds and strong insider conviction — could make DLTR a standout performer in the months ahead.

    Oxford Club

    Next “Midnight Tweet” Could Trigger Massive Gains

    Company:

    Chair, CEO, and President Melissa Smith just bought $500,720, paying an average price of earnings per share (EPS) of $3.51, beating expectations by $0.11. While BREAKING: New Algorithm Targets 2X Trades EVERY Monday Morning

    20-year trading veteran Tim Bohen has just released a brand-new trading algorithm that targets explosive stock moves every Monday morning. It recently identified SEVEN triple-digit winners in ONE MONTH – Walgreens Boots Alliance (SYM: WBA)
    $9.1 Million Insider Buy

    over $9 million on a single stock — it's more than a signal. It’s a statement.

    That’s exactly what 832,258 shares of $9.1 million.

    WBA has been one of the more embattled names in retail and healthcare, thanks in part to $350 million settlement with the U.S. Department of Justice, bringing a long-standing legal cloud closer to resolution.

    According to company spokesperson Fraser Engerman:

    “We strongly disagree with the government’s legal theory and admit no liability… This resolution allows us to close all opioid-related litigation with federal, state, and local governments and provides us with favorable terms from a cash flow perspective while we focus on our turnaround strategy.”

    With the legal overhang potentially behind it and the company pushing ahead with a deep-pocketed insider confidence could mark the bottom for WBA.

    Found this helpful? Share it with others.

    Written by Ian Cooper

    Our Flagship Publication

    Discover Great Companies Trading at a Discount

    Join Behind the Markets